Kimmo Olavi Taari
researchportal.helsinki.fi
0000-0002-0077-4896
University of Helsinki
203 papers found
Refreshing results…
Charlson Comorbidity Index Based On Hospital Episode Statistics Performs Adequately In Predicting Mortality, But Its Discriminative Ability Diminishes Over Time
Randomised Trial of Adjuvant Radiotherapy Following Radical Prostatectomy Versus Radical Prostatectomy Alone in Prostate Cancer Patients with Positive Margins or Extracapsular Extension
A 16-yr Follow-up of the European Randomized study of Screening for Prostate Cancer
Anticoagulants and cancer mortality in the Finnish randomized study of screening for prostate cancer
The association of financial difficulties and out-of-pocket payments with health-related quality of life among breast, prostate and colorectal cancer patients
Bias-corrected estimates of effects of PSA screening decisions on the risk of prostate cancer diagnosis and death: Analysis of the Finnish randomized study of screening for prostate cancer
Allopurinol and the risk of prostate cancer in a Finnish population-based cohort
Blood glucose, glucose balance, and disease-specific survival after prostate cancer diagnosis in the Finnish Randomized Study of Screening for Prostate Cancer
Tulisiko poikien HPV-rokotusten olla osa kansallista rokotusohjelmaa?
Evolving Clinical Picture of Renal Cell Carcinoma: A Population-Based Study from Helsinki
Vatsa- ja virtsaelinvammat
Costs in Different States of Breast Cancer
Radical Prostatectomy or Watchful Waiting in Prostate Cancer — 29-Year Follow-up
Clonal heterogeneity influences drug responsiveness in renal cancer assessed by ex vivo drug testing of multiple patient-derived cancer cells
Surgery for metastases of renal cell carcinoma: outcome of treatments and preliminary assessment of Leuven-Udine prognostic groups in the targeted therapy era
The Number of Screening Cycles Needed to Reduce Prostate Cancer Mortality in the Finnish Section of the European Randomized Study of Prostate Cancer (ERSPC)
Serum cholesterol and prostate cancer risk in the Finnish randomized study of screening for prostate cancer
Cancer mortality does not differ by antiarrhythmic drug use: A population-based cohort of Finnish men
Costs of screening for prostate cancer: Evidence from the Finnish Randomised Study of Screening for Prostate Cancer after 20-year follow-up using register data
Fasting blood glucose, glycaemic control and prostate cancer risk in the Finnish Randomized Study of Screening for Prostate Cancer
Missing publications? Search for publications with a matching author name.